USPTO serial 97979703
PURIST
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 11, 2025
- Examiner
- JOINER, KATINA JACKSON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PURIST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devon E. White
Devon E. White WYRICK ROBBINS YATES & PONTON LLP4101 LAKE BOONE TRAIL SUITE 300RALEIGH, NC 27607United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing medical and scientific research in the field of oncology, tumor biology, and diagnosis and treatment of cancers; Pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; Providing research and development services in the field of oncology; Research and development in the field of RNA expression, namely, cancer biology; Research and development services for others, namely, research and development of assays for oncological testing and diagnostic purposes; Scientific research in the field of RNA expression analysis and reporting; Providing laboratory research services in the field of pancreatic cancer; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Pharmaceutical and medical research in the field of survival outcomes and standard of care research; Medical research featuring the identification and validation of cancer related biomarkers and RNA expression for use in improved patient outcomes; Providing a website and information in the field of medical research and scientific research in the fields of tumor biology, oncology, and diagnosis and treatment of cancers | ACTIVE | — |
| 044 | Medical testing services for diagnosis, prognosis, treatment, and management of cancer; Medical testing for diagnostic and treatment option purposes; Providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the diagnosis, prognosis, treatment or management of cancer; Provision of health care services, namely, providing oncological testing reports to physicians | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GENECENTRIC THERAPEUTICS, INC.
- Other trademarks owned by GENECENTRIC THERAPEUTICS, INC.
- Other trademarks owned by GENECENTRIC THERAPEUTICS, INC.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PURIST
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 11, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 11, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 20, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 13, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 13, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 13, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 13, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 13, 2025 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Dec 10, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 1, 2024 | IUAF | USE AMENDMENT FILED | — |
| Oct 1, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 1, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 1, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 1, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 4, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 1, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 1, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 19, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Sep 22, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 19, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 26, 2022 | NWAP | NEW APPLICATION ENTERED | — |